iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma

Abstract Background Cytokine-induced memory-like natural killer (CIML NK) cells have been found to possess potent antitumor responses and induce complete remissions in patients with leukemia. However, the poor infiltration of transferred NK cells is a major obstacle in developing adoptive cell immun...

Full description

Bibliographic Details
Published in:	Journal of Translational Medicine
Main Authors:	Yanbing Dong, Ying Huang, Zhe Zhang, Aoxing Chen, Lin Li, Manman Tian, Jie Shen, Jie Shao
Format:	Article
Language:	English
Published:	BMC 2023-03-01
Subjects:	Memory-like NK cells Hepatocellular carcinoma iRGD
Online Access:	https://doi.org/10.1186/s12967-023-04024-7

Similar Items

Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation
by: Jie Shao, et al.
Published: (2024-12-01)

Tumor-specific delivery of KRAS siRNA with iRGD-exosomes efficiently inhibits tumor growth
by: Yu Zhou, et al.
Published: (2019-12-01)

iRGD‐Targeted Physalis Mottle Virus Like Nanoparticles for Targeted Cancer Delivery
by: Krister J. Barkovich, et al.
Published: (2023-08-01)

Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD Peptide
by: Gye Lim Kim, et al.
Published: (2023-02-01)

Correction: iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma
by: Yanbing Dong, et al.
Published: (2023-05-01)

Tumor Microenvironment-Responsive Polymeric iRGD and Doxorubicin Conjugates Reduce Spontaneous Lung Metastasis in an Orthotopic Breast Cancer Model
by: Zheng-Hong Peng, et al.
Published: (2022-08-01)

iRGD-Targeted Biosynthetic Nanobubbles for Ultrasound Molecular Imaging of Osteosarcoma
by: Liu T, et al.
Published: (2025-01-01)

iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
by: Dan Lin, et al.
Published: (2021-12-01)

Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide
by: Eltayeb E. M. Eid, et al.
Published: (2019-07-01)

Preparation and characterization of a iRGD-modified recombinant spider silk particles for antitumor polypeptide drug delivery into cancer cells
by: Ben Wang, et al.
Published: (2025-08-01)

The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation
by: Yingzheng Wang, et al.
Published: (2023-09-01)

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade
by: Yirong Wu, et al.
Published: (2025-05-01)

Molecular Imaging of Steroid-Induced Osteonecrosis of the Femoral Head through iRGD-Targeted Microbubbles
by: Ping Zhao, et al.
Published: (2022-09-01)

Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells
by: Anna Egorova, et al.
Published: (2020-10-01)

Anticancer activity of Pseudomonas aeruginosa derived peptide with iRGD in colon cancer therapy
by: Atieh Yaghoubi, et al.
Published: (2023-07-01)

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial✰
by: J. Lee, et al.
Published: (2023-10-01)

iRGD-Guided Silica/Gold Nanoparticles for Efficient Tumor-Targeting and Enhancing Antitumor Efficacy Against Breast Cancer
by: Hou X, et al.
Published: (2024-08-01)

HER-2 Receptor and αvβ3 Integrin Dual-Ligand Surface-Functionalized Liposome for Metastatic Breast Cancer Therapy
by: Dilip Kumar Arya, et al.
Published: (2024-08-01)

αvβ3 Integrin and Folate-Targeted pH-Sensitive Liposomes with Dual Ligand Modification for Metastatic Breast Cancer Treatment
by: Prashant Pandey, et al.
Published: (2024-08-01)

Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells
by: Anna Egorova, et al.
Published: (2022-11-01)

Therapeutic and diagnostic implications of exosomes as natural nanoparticles: a new paradigm in brain cancer disease management
by: Shanid Mohiyuddin, et al.
Published: (2025-07-01)

Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in miceResearch in context
by: Christian Schmithals, et al.
Published: (2024-07-01)

The construction of in vitro nasal cavity-mimic M-cell model, design of M cell-targeting nanoparticles and evaluation of mucosal vaccination by nasal administration
by: Xiaotong Yang, et al.
Published: (2020-06-01)

iRGD Tumor-Penetrating Peptide-Modified Nano-Delivery System Based on a Marine Sulfated Polysaccharide for Enhanced Anti-Tumor Efficiency Against Breast Cancer
by: Chen B, et al.
Published: (2022-02-01)

Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy
by: Valeria Sidorenko, et al.
Published: (2024-07-01)

Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy/internal irradiation combination therapy
by: Congcong Wang, et al.
Published: (2022-05-01)

MicroRNA-539-5p-Loaded PLGA Nanoparticles Grafted with iRGD as a Targeting Treatment for Choroidal Neovascularization
by: Jouri S. Alanazi, et al.
Published: (2022-01-01)

Dual-Modality Molecular Imaging of Tumor via Quantum Dots-Liposome–Microbubble Complexes
by: Jieqiong Wang, et al.
Published: (2022-11-01)

Synergistic Pro-Apoptotic Effect of a Cyclic RGD Peptide-Conjugated Magnetic Mesoporous Therapeutic Nanosystem on Hepatocellular Carcinoma HepG2 Cells
by: Xuanping Zhao, et al.
Published: (2023-01-01)

Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy
by: Jason Chiang, et al.
Published: (2023-10-01)

Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues
by: Jordan Cossu, et al.
Published: (2023-02-01)

Click Chemistry for the Synthesis of RGD-Containing Integrin Ligands
by: Matteo Colombo, et al.
Published: (2010-01-01)

Low-Molecular Weight Polyethylenimine Modified with Pluronic 123 and RGD- or Chimeric RGD-NLS Peptide: Characteristics and Transfection Efficacy of Their Complexes with Plasmid DNA
by: Jing Hu, et al.
Published: (2016-05-01)

Design of Functional RGD Peptide-Based Biomaterials for Tissue Engineering
by: Vijay Bhooshan Kumar, et al.
Published: (2023-01-01)

Histomorphometry of Ossification in Functionalised Ceramics with Tripeptide Arg-Gly-Asp (RGD): An In Vivo Study
by: Filippo Migliorini, et al.
Published: (2022-05-01)

Photodynamic Therapy Using RGD-Functionalized Quantum Dots Elicit a Potent Immune Response in a Syngeneic Mouse Model of Pancreatic Cancer
by: Li MM, et al.
Published: (2024-09-01)

Status and Advances of RGD Molecular Imaging in Lung Cancer
by: Ning YUE, et al.
Published: (2014-12-01)

New opportunities for RGD-engineered metal nanoparticles in cancer
by: Wei Qin, et al.
Published: (2023-05-01)

Design and synthesis of hydrophobic RGD-peptides derivatives
by: A. V. Dobrynina, et al.
Published: (2010-02-01)

LIC12254 Is a Leptospiral Protein That Interacts with Integrins via the RGD Motif
by: Maria F. Cavenague, et al.
Published: (2023-04-01)